Article Information
History
- January 1, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Bede Constantinides1,4,*,
- Hermione Webster1,3,
- Jessica Gentry2,
- Jasmine Bastable2,
- Laura Dunn2,
- Sarah Oakley2,
- Jeremy Swann1,
- Nicholas Sanderson1,3,
- Philip W Fowler1,3,
- Geoffrey Ma1,3,
- Gillian Rodger1,4,
- Lucinda Barrett2,
- Katie Jeffery2,5,
- Timothy EA Peto1,2,3,
- Nicole Stoesser1,4,
- Teresa Street1,3 and
- Derrick W Crook1,2,3
- 1NDM Experimental Medicine, University of Oxford, Oxford, United Kingdom
- 2Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
- 3NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom
- 4NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance in partnership with Public Health England, Oxford, United Kingdom
- 5Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom
- ↵* Corresponding author; email: bedeabc{at}gmail.com
Posted January 01, 2022.
Rapid turnaround multiplex sequencing of SARS-CoV-2: comparing tiling amplicon protocol performance
